A new study has shown that evidence of past hepatitis B infection was twice as common in people with pancreatic cancer than in healthy controls. This study is the first to report an association between past exposure to the hepatitis B virus and pancreatic cancer, but researchers cautioned that more studies are necessary to evaluate the nature of the link.
"While our findings indicate that past exposure to hepatitis B is associated with the development of pancreatic cancer, more research is needed to determine whether this relationship is one of cause and effect," said lead author Manal M. Hassan, MD, PhD, assistant professor at the University of Texas M. D. Anderson Cancer Center. "If these findings can be confirmed by other studies, hepatitis B could be another risk factor for pancreatic cancer that is readily modifiable with treatment, and even preventable with a vaccine."
In this study, Hassan and her colleagues compared evidence of hepatitis B and C infection (as determined by blood tests assessing antibodies to these viruses) between 476 patients with pancreatic cancer and 879 matched healthy individuals. Evidence of past exposure to hepatitis B was found in 7.6 percent of patients with pancreatic cancer versus 3.2 percent of controls. The association between hepatitis B exposure and pancreatic cancer remained statistically significant even after controlling for other risk factors, such as smoking. People with both diabetes (an established risk factor for pancreatic cancer) and hepatitis B exposure had a seven-fold increase in pancreatic cancer risk, compared to controls. No association was observed between hepatitis C exposure and pancreatic cancer.
The authors noted that past studies have reported the presence of hepatitis B antigens in pancreatic fluids; others have identified impaired pancreatic function in people with chronic hepatitis B infection. These findings suggest that the hepatitis B virus may cause inflammation or DNA damage in the pancreas, which could increase cancer risk.
The researchers also indicated that there may be an increased risk of liver failure after chemotherapy treatment among patients with pancreatic cancer who have a history of hepatitis B infection. Dr. Hassan noted that if their findings are confirmed, oncologists may want to consider checking the hepatitis B status of their patients with pancreatic cancer before beginning chemotherapy.
Pancreatic cancer is estimated to strike 37,680 people in the U.S. in 2008, taking 34,290 lives. Because it is usually advanced by the time patients experience symptoms, it is very difficult to cure. Smoking and diabetes raise the risk of pancreatic cancer, but the disease also develops in people without these risk factors.
Two million people in the U.S. are currently living with chronic hepatitis B infection. While most new cases in previously healthy adults are cleared by the immune system within a few months, many people – especially those infected as newborns and children – develop chronic, lifelong infections.
Patrick J. Loehrer, Sr., MD, deputy director and medical director of the Indiana University Cancer Center, notes, “Pancreatic cancer is an aggressive disease that is very difficult to treat successfully. In large part, it is a result of the inability to prevent and diagnose early as treatment for advanced disease is palliative at best. If these data are confirmed by larger studies, they would highlight a new risk factor for this lethal cancer, a virus for which both treatment and a vaccine already exist. Whether this could then lead to an impact in the incidence of this disease requires further study."
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.